PRATESI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 17.709
AS - Asia 4.785
EU - Europa 3.452
SA - Sud America 815
Continente sconosciuto - Info sul continente non disponibili 381
AF - Africa 281
OC - Oceania 5
Totale 27.428
Nazione #
US - Stati Uniti d'America 15.094
CA - Canada 2.517
SG - Singapore 1.388
CN - Cina 1.350
IT - Italia 1.031
HK - Hong Kong 805
BR - Brasile 654
SE - Svezia 558
VN - Vietnam 419
DE - Germania 356
BG - Bulgaria 308
GB - Regno Unito 286
FR - Francia 169
TR - Turchia 157
FI - Finlandia 154
RU - Federazione Russa 151
IN - India 133
UA - Ucraina 133
CI - Costa d'Avorio 108
JP - Giappone 106
KR - Corea 90
BD - Bangladesh 81
AT - Austria 69
AR - Argentina 61
CH - Svizzera 52
BE - Belgio 50
IQ - Iraq 44
NG - Nigeria 38
MX - Messico 37
SN - Senegal 32
ZA - Sudafrica 29
ID - Indonesia 26
PK - Pakistan 26
PL - Polonia 26
UZ - Uzbekistan 25
SA - Arabia Saudita 24
ES - Italia 23
NL - Olanda 21
VE - Venezuela 21
EC - Ecuador 19
CO - Colombia 16
PY - Paraguay 14
NP - Nepal 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
GR - Grecia 11
IL - Israele 11
JO - Giordania 11
KE - Kenya 11
MA - Marocco 11
UY - Uruguay 11
CR - Costa Rica 10
EG - Egitto 10
IR - Iran 9
CL - Cile 8
JM - Giamaica 8
ET - Etiopia 7
LT - Lituania 7
TN - Tunisia 7
BB - Barbados 6
HN - Honduras 6
LB - Libano 6
PE - Perù 6
TT - Trinidad e Tobago 6
AU - Australia 5
BJ - Benin 5
DZ - Algeria 5
EU - Europa 5
IE - Irlanda 5
OM - Oman 5
PH - Filippine 5
RS - Serbia 5
TH - Thailandia 5
TW - Taiwan 5
AL - Albania 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
MY - Malesia 4
NI - Nicaragua 4
PA - Panama 4
AO - Angola 3
AZ - Azerbaigian 3
BY - Bielorussia 3
CG - Congo 3
GT - Guatemala 3
HU - Ungheria 3
MD - Moldavia 3
PS - Palestinian Territory 3
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
BO - Bolivia 2
BS - Bahamas 2
BW - Botswana 2
GE - Georgia 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
PR - Porto Rico 2
Totale 27.021
Città #
Dallas 6.155
Montreal 2.331
Woodbridge 982
Ashburn 892
Hong Kong 792
Ann Arbor 729
Singapore 714
Fairfield 615
Houston 591
Santa Clara 582
San Jose 541
Chandler 539
Sofia 306
Shanghai 300
Beijing 297
Milan 288
Seattle 250
New York 236
Wilmington 231
Cambridge 175
Boardman 158
Jacksonville 148
Los Angeles 147
Pisa 147
Princeton 147
Ottawa 139
Lawrence 120
Hefei 117
Lauterbourg 114
Medford 109
Abidjan 108
Nanjing 108
Ho Chi Minh City 102
Tokyo 100
Council Bluffs 99
Serra 91
Lancaster 84
Des Moines 83
Seoul 83
Izmir 79
Hanoi 72
Dong Ket 64
Vienna 64
London 63
Buffalo 58
Munich 58
Livorno 47
São Paulo 45
Istanbul 44
Brussels 43
San Diego 41
Bern 40
Rome 40
Nanchang 38
Frankfurt am Main 37
Helsinki 37
Lagos 37
Redondo Beach 36
Bremen 32
Dakar 32
Florence 32
Orem 32
Chicago 30
Rio de Janeiro 29
Dearborn 28
Jüchen 26
Ogden 25
Redwood City 25
Turku 24
Dhaka 23
Tashkent 23
Columbus 22
Nuremberg 22
North Bergen 21
Warsaw 20
Tianjin 19
Baghdad 18
Hebei 18
Kunming 18
Auburn Hills 17
Chennai 17
Jiaxing 16
Fuzhou 15
Changsha 14
Da Nang 14
Pune 14
San Francisco 14
Shenyang 14
Brasília 13
Mexico City 13
Phoenix 13
The Dalles 13
Belo Horizonte 12
Mumbai 12
Nürnberg 12
Quanzhou 12
Asunción 11
Atlanta 11
Curitiba 11
Haiphong 11
Totale 21.491
Nome #
08.20 Acpa fingerprinting in established rheumatoid arthritis 8.516
Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy: A possible role in drug resistance 351
Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis 207
A Straightforward Method to Produce Multi-Nanodrug Delivery Systems for Transdermal/Tympanic Patches Using Electrospinning and Electrospray 206
Anti-endothelial cells antibodies and anti-DNA antibodies in systemic lupus erythematosus sera. 195
Renal Involvement in IgG4-Related Disease: From Sunlight to Twilight 185
A novel DNA/histone H4 peptide complex detects autoantibodies in systemic lupus erythematosus sera 182
Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience 178
IL-18 activity in systemic lupus erythematosus 178
ANTI-CITRULLINATED ALPHA ENOLASE ANTIBODIES, INTERSTITIAL LUNG DISEASE AND BONE EROSION IN RHEUMATOID ARTHRITIS 176
A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population 175
Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. 175
Alpha-Enolase is an autoantigen in systemic autoimmune disorders. 175
Potential biomarkers in patients with systemic sclerosis 174
NETosis as Source of Autoantigens in Rheumatoid Arthritis 174
A family-based study shows no association between rheumatoid arthritis and the PADI4 gene in a French caucasian population 173
Autoantibodies in Systemic Lupus: Quite a Lot or Just a Few? 173
The immune response to citrullinated antigens in autoimmune diseases 172
IL-1 family cytokines and receptors in IgG4-related disease 170
Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies. 170
Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies 169
Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis 169
Mediators of angiogenesis and fibrosis in IgG4-related disease. 168
CCL5/RANTES, sVCAM-1, and sICAM-1 in chronic spontaneous urticaria. 168
The targets of nephritogenic antibodies in systemic autoimmune disorders 166
Endostatin and Thrombospondin-1 levels are increased in the sera of patients with chronic spontaneous urticaria. 166
Prevalenza degli anticorpi anti-Saccharomices Cerevisiae nei pazienti affetti da spondilite anchilosante ed artrite psoriasica 164
ACPA and shared epitope: The behaviour of anti-viral citrullinated peptide antibodies 164
Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria. 163
Alpha-enolase and anti-alpha-enolase antibodies in systemic lupus. 163
IL-18 in autoimmunity. Studies in autoimmune murine lupus and in human SLE 162
Detection of anti-ribosomal P protein antibodies by means of synthetic peptides 161
Effect of Interferon-α and β on FAS mediated apoptosis and IL-6 release in Human primary thyrocytes 160
Peptidylarginine deiminase 4 and citrullination in health and disease 160
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature. 160
Deiminated Epstein Barr virus nuclear antigen I is a target of anti-citrullinated protein antibodies in rheumatoid arthritis 159
Endothelial cell binding by systemic lupus antibodies: functional properties and relationship with anti-DNA activity 159
Surface plasmon resonance method to evaluate anti-citrullinated protein/peptide antibody affinity to citrullinated peptides 158
Fingerprinting of anti-citrullinated protein antibodies (ACPA): Specificity, isotypes and subclasses 158
Mechanism of renal damage in systemic autoimmune disorders 154
Modified peptides as diagnostic tools for autoimmune diseases: A chemical reverse approach 153
Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders 153
IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders 152
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X(4) 152
Multi-antibody composition in lupus nephritis: Isotype and antigen specificity make the difference 152
Evaluation of the pathogenic role of anti-alpha enolase antibodies in autoimmune disorders. 151
Antibodies to viral citrullinated Peptide in rheumatoid arthritis 149
Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease? 148
IL-1 family cytokines and soluble receptors in systemic lupus erythematosus 148
Anti-ribosomal P protein antibodies bind cardiolipin 147
Autoantibodies and nephritis: different roads may lead to Rome 147
Analysis of the peptidylarginine deiminase V gene in rheumatoid arthritis 146
Anti-Alpha-Enolase antibodies in mixed cryoglobulinemia. 146
Anti-alpha enolase multi-antibody specificity in human diseases. Clinical significance and molecular mechanisms 146
Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies 145
The peptidylarginine deiminase V gene: a candidate gene in rheumatoid arthritis 145
Heart- and skeletal muscle-specific antigens recognized by trichinellosis patient sera 145
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 145
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 145
Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies 145
COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases 144
Anti-citrullinated protein antibodies (ACPA) and antibodies to exogenous antigens in follow-up study of rheumatoid arthritis patients 143
Method for the diagnosis of rheumatoid arthritis 143
Anti-ribosomal antibodies from lupus patients bind DNA 142
IgA antibodies to tissue transglutaminase in patients affected by ankilosing spondylitis and psoriatic arthritis 141
Flow cytometric single-cell analysis of cytokine production by CD3+ T-cells in synovial fluid from patients with psoriatic arthritis. 141
Alpha-enolase is a renal specific antigen associated with kidney involvement in mixed cryoglobulinemia 140
Endogenous anti-C1q antibodies do not interfere with the C1qScreen™ assay. 140
Neutrophil Extracellular Traps protein composition is specific for patients with Lupus nephritis and includes methyl-oxidized αenolase (methionine sulfoxide 93). 140
Antibodies to tissue transglutaminase and Saccharomyces cerevisiase in ankylosing spondylitis and psoriatic arthritis 139
A new autoantigen, alpha-enolase. 139
Neutrophil extracellular traps (NET) induced by different stimuli: A comparative proteomic analysis. 138
The 'Chemical Reverse Approach to identify autoantibodies in Systemic Lupus Erithematosus patients. 137
New biomarkers in SLE: from bench to bedside 137
Anti-enolase antibodies and renal damage. 136
Something old, something new: biomarkers in rheumatoid arthritis 136
Interleukin‐1 family cytokines and soluble receptors in hidradenitis suppurativa 135
Multiple Autoantibody Cross-reactivity in Connective Tissue Diseases 134
Autoantibodies specific for alpha-enolase in systemic autoimmune disorders 134
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis. 134
CXCL12/SDF-1 in IgG4-Related Disease 134
Bnt162b2 mRNA SARS‐CoV‐2 vaccine elicits high avidity and neutralizing antibodies in healthcare workers 134
Surface expression of an autoantigen, alpha-enolase. 133
Allergy Workup in the Diagnosis of COVID-19 Vaccines-Induced Hypersensitivity Reactions and Its Impact on Vaccination 132
The interleukin-1 family cytokines and receptors in autoimmune and autoinflammatory diseases 132
Anti Citrullinated Peptide Antibodies profiling in established rheumatoid arthritis 132
Shotgun proteomics, in-silico evaluation and immunoblotting assays for allergenicity assessment of lesser mealworm, black soldier fly and their protein hydrolysates. 132
Anti-glutathione S-transferase omega 1-1 (GSTO1-1) antibodies are increased during acute and chronic inflammation in humans 131
Structure and function of an autoantigen, alpha-enolase. 131
Cytokine Release from Stimulated PBMC after-HSCT: Results of a Post-Transplant Zinc Oral Supplementation Trial (ZENITH). 131
Histone Protein Epitope Mapping for Autoantibody Recognition in Rheumatoid Arthritis. 131
HISTONE CITRULLINATED PEPTIDES AND USES THEREOF 129
Endostatin and Thrombospondin-1 levels are increased in the sera of patients with chronic spontaneous urticaria 129
HLA Shared Epitope and ACPA: just a marker or an active player? 127
Cytokines and soluble receptors of the interleukin-1 family in Schnitzler syndrome 127
Analysis of the peptidyl arginine deiminase V gene in rheumatoid arthritis 126
Alpha-enolase as plasminogen receptor: the activity of the autoantibodies in the receptor function. 126
Viral citrullinated peptides and uses thereof 125
Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus. 125
Mechanisms of renal damage in mixed cryoglobulinaemia nephritis 124
Totale 23.680
Categoria #
all - tutte 64.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.278 0 72 28 73 226 181 31 61 62 54 90 400
2022/20231.667 202 227 102 164 184 273 36 83 300 6 76 14
2023/20243.735 160 144 165 175 194 214 75 43 31 2.337 36 161
2024/20254.373 56 150 56 204 399 390 364 216 412 503 425 1.198
2025/202610.111 259 2.009 4.725 534 388 400 616 213 235 487 143 102
2026/2027291 147 144 0 0 0 0 0 0 0 0 0 0
Totale 27.428